☆ 4.6 Meeting Abstract

Efficacy and safety of sepofarsen, an intravitreal RNA antisense oligonucleotide, for the treatment of CEP290-associated Leber congenital amaurosis (LCA10): a randomized, double-masked, sham-controlled, Phase 3 study (ILLUMINATE)

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Add to Collection

Journal

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Volume 63, Issue 7, Pages -

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Keywords

-

Categories

Ophthalmology

Funding

  1. Research Foundation Flanders, Senior Clinical Investigator Award [1803821N]
  2. Concerted Research Action of the Special Research Fund Ghent University [BOF20/GOA/023]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.